The Asian Private Equity & Venture Capital Awards

11 November 2019 l Island Shangri-La Hong Kong

As the industry's premier information source, the Asian Venture Capital Journal tasks itself with highlighting the firms, professionals, investments, exits and fundraises that are a cut above the rest. We do this on an ongoing basis through our editorial coverage and annually through our awards. As such, we are proud to introduce the 19th AVCJ Private Equity & Venture Capital Awards.

The Awards have become a mark of distinction in Asian private equity, and a showcase for first-class innovation, ingenuity and performance. They are also unique in the region in how they are distributed - relying primarily on nominations and votes cast by Asia's entire private equity and venture capital community, but with contributions from a select panel of industry judges as well as the AVCJ Editorial Board. To be selected as a winner is to be truly acknowledged as preeminent.

AVCJ Award Winners 2019

PAG claimed three out of the 16 prizes presented, adding the fundraising and deal of the year awards to its firm of the year title – each one in the large-cap category. Ramnath’s award capped a strong showing by India’s private equity community, with A91 Ventures and ChrysCapital Partners triumphing in the VC and mid-cap fundraising categories and Gaja Capital taking the operational value-add prize for its work on EuroKids International.

Pacific Equity Partners took the mid-cap exit award for Manuka Health, 12 months after the same company won the responsible investment prize. Its successor in that category was Organica, a Vietnam-based retailer and wholesaler of organic foods and beverages backed by SEAF. CBC Group, CITIC Capital, Unison Capital, and KKR were among the other winners.

Collecting the firm of the year award, David Kim, a partner and COO at PAG, reflected on how far the organization has come since Weijian Shan moved over from TPG Capital in 2010 and started the PAG private equity team with a “relatively small group of professionals." He said: "Ten years later, we are up to 49 professionals on the buyout side and we have nine members in our growth fund. We’ve done three fundraisings on the buyout side and one on the growth side."

Innovent Biologics (6 Dimensions Capital/Ally Bridge Group/Capital Group Private Markets/Cormorant Asset Management/Cowin Capital/Eight Roads Ventures/F-Prime Capital/Hillhouse Capital/Legend Capital/Lilly Asia Ventures/Rock Springs Capital/Temasek Holdings)

Awards Sponsors